Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a cancer peptide vaccine in combination with GM-CSF as adjuvant for breast cancer; the study is active but not currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cancer peptide vaccine (peptide vaccine)
  • GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Herbert Lyerly | Conditions: Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING